🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Dublin
Clinical trial register · Ireland

Clinical Trials in Dublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 615 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
321
Recruiting now
open to new participants
180
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 321 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC 36 University College Dublin 21 Royal College of Surgeons, Ireland 18 AbbVie 16 Bristol-Myers Squibb 14
Site location
Dublin 483 Cork 170 Galway 124 Limerick 56 Waterford 51
All 37 locations
Target enrolment
to

Trials with a site in Dublin

483 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
Remote Assessment of Signs and Symptoms in Palliative Care
NCT06587321 Palliative Care, Vital Signs, Remote Monitoring
Our Lady's Hospice and Care Services
Observational
30
Dublin
2024-04-01
Recruiting
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
NCT06093672 Polycythemia Vera
Italfarmaco
Phase 3
220
Cork, Dublin
2024-03-26
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871 HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1
383
Dublin, Cork
2024-03-25
Active, closed
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
NCT06257875 Ulcerative Colitis
AbbVie
Phase 2
156
Elm Park, Dublin
2024-03-23
Active, closed
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
NCT06263946 Myopia
Essilor International
Not applicable
150
Dublin
2024-03-22
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
NCT06072781 Low Grade Serous Ovarian Cancer
Verastem, Inc.
Phase 3
270
Dublin
2024-03-18
Recruiting
The NEU-STIM Trial
NCT05942924 Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Dublin, Galway
2024-03-11
Active, closed
ProVIDE II Bridging Study
NCT06236802 BPH With Symptomatic Lower Urinary Tract Symptoms
ProVerum Medical
Not applicable
40
Dublin
2024-03-06
Recruiting
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
NCT06302348 Phenylketonuria
PTC Therapeutics
Phase 3
56
Dublin
2024-03-04
Recruiting
H. Pylori Screen-and-treat Study in a Population of Young Adults
NCT06275204 Gastric Cancer, H Pylori Infection, H Pylori Eradication, H-pylori
University of Latvia
Observational
6,800
Dublin
2024-03-04
Recruiting
PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations
NCT06025253 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
728
Dublin, Galway, Limerick, Waterford
2024-03-01
Recruiting
Supporting University Students Transition Towards Sustainable and Healthy Dietary Behaviours: A Living Lab Approach.
NCT06939231 Dietary Behaviours, Sustainable Healthy Diet, Personalised Nutrition
University College Dublin
Not applicable
520
Dublin
2024-02-26
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
NCT05979311 HIV, HIV Infections
ViiV Healthcare
Phase 3
307
Dublin
2024-02-21
Active, closed
Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
NCT05930275 Crohn's Disease
AbbVie
Observational
1,200
Ballinasloe, Dublin
2024-02-19
Recruiting
Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)
NCT06024824 Pancreatic Adenocarcinoma
Cancer Trials Ireland
Phase 1/2
49
Dublin
2024-01-30
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
NCT06079398 Achondroplasia
Ascendis Pharma A/S
Phase 2
72
Dublin
2024-01-23
Recruiting
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
NCT05970172 Chronic Kidney Disease, Renal Anemia
Astellas Pharma Global Development, Inc.
Phase 3
100
Dublin
2024-01-16
Recruiting
Occupational Therapy-led Services for Adults Presenting Acutely With a Hand Condition
NCT06399614 Hand Injuries
University of Limerick
Observational
150
Dublin, Galway, Limerick, Tipperary
2024-01-11
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931 Transthyretin Amyloid Cardiomyopathy
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Dublin
2024-01-11
Recruiting
PICSI Impact on Euploidy in Assisted Reproduction
NCT06602687 Infertility
Merrion Fertility Clinic
Not applicable
142
Dublin
2024-01-01
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT06136624 Prostate Cancer Metastatic
Merck Sharp & Dohme LLC
Phase 3
1,310
Dublin
2023-12-31
Recruiting
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT05950945 Breast Cancer
Daiichi Sankyo
Phase 3
250
Cork, Dublin, Galway
2023-12-30
Recruiting
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
NCT06247085 Homocystinuria
Travere Therapeutics, Inc.
Phase 3
70
Dublin
2023-12-28
Recruiting
Affera Global Registry
NCT06026345 Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
540
Dublin
2023-12-22
Recruiting
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
NCT05912517 Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Phase 3
120
Dublin
2023-12-20
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650 Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,314
Dublin
2023-12-18
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
NCT06285318 Relapsed/Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd.
Observational
900
Cork, Dublin, Galway
2023-12-18
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364 ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Dublin, Waterford
2023-12-15
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
NCT06091865 Diffuse Large B-cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals
Phase 3
904
Dublin
2023-12-13
Active, closed
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
NCT06132958 Endometrial Cancer
Merck Sharp & Dohme LLC
Phase 3
710
Cork, Dublin
2023-12-06
Active, closed
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
NCT06077760 Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
868
Dublin
2023-12-06
Active, closed
U011 - Wireless Ultra Long-Term EEG Recordings in Epilepsy
NCT05915988 Epilepsy
UNEEG Medical A/S
Not applicable
19
Cork, Dublin
2023-12-04
Recruiting
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases
NCT06078813 Solid Tumor Spine Metastases
Cancer Trials Ireland
Phase 1/2
126
Cork, Dublin
2023-11-21
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640 Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Dublin
2023-11-14
Not yet open
Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial
NCT06115629 Esophageal Cancer, Gastric Cancer
University of Dublin, Trinity College
Phase 3
952
Cork, Dublin, Galway
2023-11
Not yet open
Study Comparing Platelet Transfusion Volumes in Premature Babies
NCT06095648 Thrombocytopenia, Transfusion
University College Dublin
Not applicable
370
Dublin
2023-10-28
Recruiting
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
NCT05658497 Multiple Sclerosis
Biogen
Observational
908
Dublin
2023-10-27
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608 Non-Small Cell Lung Cancer
Summit Therapeutics
Phase 3
1,600
Dublin, Galway
2023-10-26
Active, closed
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT05710666 HER2-positive Breast Cancer
Cancer Trials Ireland
Phase 2
11
Galway, Dublin, Cork, Limerick
2023-10-26
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
NCT06025578 Progressive Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
1,057
Drogheda, Dublin
2023-10-25
Recruiting
The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
NCT06297005 Vaping, Pregnancy Related, Pediatric Respiratory Diseases
University College Dublin
Observational
1,200
Dublin
2023-10-09
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557 Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Recruiting
Palliative Care and Oncology Survey on Terminology
NCT05871996 Cancer
Our Lady's Hospice and Care Services
Observational
1,532
Dublin
2023-10-03
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
NCT06003426 Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
1,255
Drogheda, Dublin
2023-09-14
By invitation
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
NCT05979441 Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis
argenx
Phase 3
240
Dublin
2023-09-12
Recruiting
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
NCT05722938 Community-acquired Pneumonia
Biotest
Phase 3
590
Dublin, Galway
2023-09-09
Recruiting
TQ-PAL Development and Validation
NCT06588933 Altered Taste
Prof Andrew Davies
Observational
200
Dublin
2023-09-01
By invitation
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
NCT05883748 Erythropoietic Protoporphyria
Disc Medicine, Inc
Phase 2/3
230
Dublin
2023-08-31
By invitation
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
NCT05962398 Hemophilia B
CSL Behring
Observational
56
Dublin
2023-08-30
Recruiting
An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer
NCT06287294 Taste, Altered, Xerostomia, Neoplasms
Our Lady's Hospice and Care Services
Observational
120
Dublin
2023-08-30
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754 Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Dublin
2023-08-17
Active, closed
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NCT05977816 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
2,000
Castlebar, Dublin, Galway, Letterkenny, Limerick, Sligo, Waterford
2023-07-14
Recruiting
Early Detection & Intervention of Cerebral Palsy in Ireland
NCT05907837 Cerebral Palsy, Neurodevelopmental Disorders
University College Cork
Observational
1,500
Cork, Dublin, Limerick
2023-07-01
Recruiting
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
NCT06016946 Friedreich Ataxia
Friedreich's Ataxia Research Alliance
Observational
3,000
Dublin
2023-06-28
By invitation
A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
NCT05929807 Achondroplasia
Ascendis Pharma Growth Disorders A/S
Phase 2/3
140
Dublin
2023-06-21
Active, closed
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
NCT05889182 Hidradenitis Suppurativa
AbbVie
Phase 3
1,328
Dublin, Cork, Galway, Waterford
2023-06-21
Active, closed
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942 Ulcerative Colitis
Alfasigma S.p.A.
Observational
509
Cork, Dublin
2023-06-12
Active, closed
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
NCT05673187 NSCLC Stage IV, KRAS P.G12C
ETOP IBCSG Partners Foundation
Phase 2
68
Dublin, Limerick, Waterford
2023-06-12
Recruiting
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
NCT05815745 Bradycardia, Pacing, Right Ventricular Pacing, His Bundle Pacing
Imperial College London
Not applicable
2,600
Dublin
2023-06-05
Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
NCT05714085 Heart Failure, Left Ventricular Systolic Dysfunction
Merck Sharp & Dohme LLC
Phase 2/3
342
Dublin
2023-05-31
Active, closed
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566 Small Cell Lung Cancer (SCLC)
Amgen
Phase 3
509
Dublin
2023-05-31
Active, closed
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
NCT05876754 Cholangiocarcinoma
Servier Affaires Médicales
Phase 3
299
Cork, Dublin
2023-05-03
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817 Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
Phase 3
880
Dublin
2023-04-25
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973 Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Cork, Dublin, Galway
2023-04-25
Active, closed
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05611931 Endometrial Cancer
Karyopharm Therapeutics Inc
Phase 3
257
Dublin, Cork, Galway, Waterford
2023-04-18
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
NCT05768139 Breast Cancer, Solid Tumors, Adult
Eli Lilly and Company
Phase 1/2
880
Dublin
2023-04-17
Recruiting
CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery
NCT05793554 Rectum Neoplasm, Rectum Polyp, Rectal Cancer
Mater Misericordiae University Hospital
Observational
600
Dublin
2023-03-31
Active, closed
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
NCT05501873 Atrial Fibrillation
Boston Scientific Corporation
Observational
1,173
Dublin
2023-03-24
Active, closed
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT05445778 Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
AbbVie
Phase 3
520
Dublin, Cork, Galway, Sligo, Waterford
2023-03-15
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
NCT05677971 Alpha1-Antitrypsin Deficiency
Takeda
Phase 3
160
Dublin
2023-03-06
Active, closed
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
NCT05669755 Cardiovascular Disease
Novo Nordisk A/S
Phase 3
7,101
Galway, Dublin
2023-03-01
Active, closed
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
NCT05741476 Allergy, Peanut
DBV Technologies
Phase 3
600
Cork, Dublin
2023-02-21
Active, closed
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
NCT05711940 Treatment Resistant Depression
COMPASS Pathways
Phase 3
572
Dublin, Galway
2023-02-14
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238 Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Dublin
2023-02-13
Recruiting
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
NCT05347238 Late-Onset Neonatal Sepsis, Extreme Prematurity, Neonatal Hypotension
Mount Sinai Hospital, Canada
Observational
550
Cork, Dublin
2023-02-06
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
NCT05327686 Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Renal Cell Carcinoma
NRG Oncology
Phase 2
240
Dublin
2023-02-01
Active, closed
ABTECT - Maintenance
NCT05535946 Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Mullingar, Dublin
2023-01-16
Active, closed
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
NCT05608291 Melanoma
Regeneron Pharmaceuticals
Phase 3
1,564
Galway, Cork, Dublin
2023-01-16
Active, closed
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
NCT05617677 Systemic Lupus Erythematosus
Bristol-Myers Squibb
Phase 3
516
Manorhamilton, Cork, Dublin
2023-01-12
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184 Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
AbbVie
Phase 1
256
Dublin
2023-01-11
Active, closed
Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
NCT05429268 Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma
Incyte Corporation
Phase 3
82
Cork, Dublin, Galway
2022-12-23
Recruiting
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
NCT05669950 Congenital Adrenal Hyperplasia
H. Lundbeck A/S
Phase 1/2
42
Dublin
2022-12-19
Active, closed
A Study Evaluating the Safety and Tolerability of QRL-201 in ALS
NCT05633459 Amyotrophic Lateral Sclerosis
QurAlis Corporation
Phase 1
69
Dublin
2022-12-16
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
NCT05232916 Breast Cancer
Greenwich LifeSciences, Inc.
Phase 3
2,250
Dublin
2022-12-16
Recruiting
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
NCT05327894 Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Dublin
2022-12-15
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654 Triple Negative Breast Cancer
Gilead Sciences
Phase 3
1,514
Dublin, Limerick, Wilton
2022-12-12
Recruiting
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
NCT05340582 Patent Ductus Arteriosus After Premature Birth
Mount Sinai Hospital, Canada
Phase 2
310
Dublin
2022-12-12
Recruiting
Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome
NCT06030349 Obstructive Sleep Apnea, Down Syndrome, Quality of Life, Behavior
Children's Health Ireland
Observational
200
Dublin
2022-11-28
Recruiting
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324 Amyotrophic Lateral Sclerosis
Corcept Therapeutics
Phase 2
279
Dublin
2022-11-15
Active, closed
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
NCT05444257 Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
Phase 3
822
Cork, Dublin, Limerick
2022-11-08
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651 Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Cork, Dublin, Waterford
2022-10-24
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296 Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Galway, Dublin, Cork, Waterford
2022-10-14
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054 Breast Neoplasms
Eli Lilly and Company
Phase 3
8,000
Cork, Dublin, Galway, Sligo, Waterford
2022-10-04
Active, closed
APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
NCT05608707 Appetite Loss, Physical Inactivity, Undernutrition, Anorexia of Aging
University College Dublin
Not applicable
180
Dublin
2022-09-22
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085 Relapsed or Refractory Multiple Myeloma
Celgene
Phase 3
810
Galway, Cork, Dublin, Limerick
2022-09-20
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047 Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Cork, Dublin, Galway
2022-09-19
Active, closed
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
NCT05450692 Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
594
Cork, Dublin, Limerick
2022-09-15
Recruiting
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
NCT04796545 AMD, Age-Related Macular Degeneration
VisionCare, Inc.
Not applicable
76
Dublin
2022-09-13
Recruiting
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
NCT05613023 Prostate Cancer
Institute of Cancer Research, United Kingdom
Phase 3
1,128
Cork, Dublin, Limerick
2022-09-09
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797 Multiple Myeloma
European Myeloma Network B.V.
Phase 3
1,594
Cork, Dublin, Galway, Limerick
2022-09-08
Rows per page Showing 201–300 of 483
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/dublin?page=3

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 615 studies in total at the last sync on 23 Sep 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 483 of those studies with a site in Dublin.

How many clinical trials are recruiting in Dublin?

246 of the 483 studies on this page are recruiting new participants as of the 23 Sep 2026, 03:15 UTC sync. A further 19 have not yet opened recruitment, 203 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.